Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 48 Records) |
| Query Trace: Neoplasms and UGT1A7[original query] |
|---|
| Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients. Therapeutic drug monitoring 2008 Oct 30 (5): 559-64. Miura Masatomo, Kagaya Hideaki, Satoh Shigeru, Inoue Kazuyuki, Saito Mitsuru, Habuchi Tomonori, Suzuki Tosh |
| Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Mar 17 (3): 695-701. Lankisch Tim O, Schulz Christoph, Zwingers Thomas, Erichsen Thomas J, Manns Michael P, Heinemann Volker, Strassburg Christian |
| Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 May 27 (15): 2457-65. Cecchin Erika, Innocenti Federico, D'Andrea Mario, Corona Giuseppe, De Mattia Elena, Biason Paola, Buonadonna Angela, Toffoli Giusep |
| Genetic polymorphisms in the tobacco smoke carcinogens detoxifying enzyme UGT1A7 and the risk of head and neck cancer. Head & neck 2009 Oct 31 (10): 1274-81. Lacko Martin, Roelofs Hennie M J, te Morsche Rene H M, Voogd Adri C, Ophuis Michael B Oude, Peters Wilbert H M, Manni Johannes |
| Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: clinical and pharmacogenetic results. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011 Apr 22 (4): 890-6. Park S R, Kong S-Y, Rhee J, Park Y-I, Ryu K W, Lee J H, Kim Y-W, Choi I J, Kim C G, Lee J Y, Cho S-J, Kim N |
| UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy. British journal of cancer 2010 Aug 103 (4): 581-9. Martinez-Balibrea E, Abad A, Martínez-Cardús A, Ginés A, Valladares M, Navarro M, Aranda E, Marcuello E, Benavides M, Massutí B, Carrato A, Layos L, Manzano J L, Moreno |
| Polymorphisms in CYP2A13 and UGT1A7 genes and head and neck cancer susceptibility in North Indians. Oral diseases 2010 Nov 16 (8): 760-8. Sharma R, Ahuja M, Panda Nk, Khullar |
| [Association between genetic polymorphism of UGT1A7 and susceptibility of bladder cancer]. Zhonghua yi xue za zhi 2009 Dec 89 (44): 3122-5. Liu Jian, Yang Xiao-ming, Liu Gang, Chang Lian-sheng, Zhang Li-rong, Song Dong-k |
| Interactions among genetic variants in tobacco metabolizing genes and smoking are associated with head and neck cancer susceptibility in North Indians. DNA and cell biology 2011 Aug 30 (8): 611-6. Sharma Rajni, Ahuja Monica, Panda Naresh K, Khullar Mad |
| Genetic polymorphisms of UGT1A7 and cancer risk: evidence from 21 case-control studies. Cancer investigation 2011 Dec 29 (10): 645-54. Lu Pei-Hua, Chen Min-Bin, Wu Xiao-Yang, Gu Jin-Hua, Liu Yuan, Gu Rong-M |
| Association between polymorphisms in UDP-glucuronosyltransferase 1A6 and 1A7 and colorectal cancer risk. Asian Pacific journal of cancer prevention : APJCP 2012 13 (5): 2311-4. Osawa Kayo, Nakarai Chiaki, Akiyama Minami, Hashimoto Ryuta, Tsutou Akimitsu, Takahashi Juro, Takaoka Yuko, Kawamura Shiro, Shimada Etsuji, Tanaka Kenichi, Kozuka Masaya, Yamamoto Masahiro, Kido Yoshia |
| Polymorphisms in heterocyclic aromatic amines metabolism-related genes are associated with colorectal adenoma risk. International journal of molecular epidemiology and genetics 2012 3 (2): 96-106. Eichholzer Monika, Rohrmann Sabine, Barbir Aline, Hermann Silke, Teucher Birgit, Kaaks Rudolf, Linseisen Jak |
| Combined effect of genetic polymorphisms in phase I and II biotransformation enzymes on head and neck cancer risk. Head & neck 2013 Jun 35 (6): 858-67. Lacko Martin, Voogd Adri C, Roelofs Hennie M J, te Morsche Rene H M, Oude Ophuis Michel B, Peters Wilbert H M, Manni Johannes |
| The association between UGT1A7 polymorphism and cancer risk: a meta-analysis. Cancer epidemiology 2012 Aug 36 (4): e201-6. Han Shuang-Xi, Wang Li, Wu De-Qu |
| Passive cigarette smoke exposure during various periods of life, genetic variants, and breast cancer risk among never smokers. American journal of epidemiology 2012 Feb 175 (4): 289-301. Anderson Laura N, Cotterchio Michelle, Mirea Lucia, Ozcelik Hilmi, Kreiger Nan |
| UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in Japan. Cancer science 2013 Dec 104 (12): 1662-9. Hazama Shoichi, Mishima Hideyuki, Tsunedomi Ryouichi, Okuyama Yusuke, Kato Takeshi, Takahashi Ken-ichi, Nozawa Hiroshi, Ando Hideaki, Kobayashi Michiya, Takemoto Hiroyoshi, Nagata Naoki, Kanekiyo Shinsuke, Inoue Yuka, Hamamoto Yoshihiko, Fujita Yusuke, Hinoda Yuji, Okayama Naoko, Oba Koji, Sakamoto Jun-ichi, Oka Masaa |
| S-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: a prospective phase II study and pharmacogenetic analysis. British journal of cancer 2013 Sep 109 (6): 1420-7. Kim S Y, S Hong Y, K Shim E, Kong S-Y, Shin A, Baek J Y, Jung K |
| [Influence of genetic polymorphisms in UGT1A1, UGT1A7 and UGT1A9 on the pharmacokynetics of irinotecan, SN-38 and SN-38G]. Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria 0 37 (2): 111-27. Valenzuela Jiménez B, González Sales M, Escudero Ortiz V, Martínez Navarro E, Pérez Ruixo C, Rebollo Liceaga J, González Manzano R, Pérez Ruixo J |
| Polymorphic expression of UDP-glucuronosyltransferase UGTlA gene in human colorectal cancer. PloS one 2013 8 (2): e57045. Wang Min, Sun De-Feng, Wang Shuai, Qing Ying, Chen Shuo, Wu Dong, Lin Ying-Min, Luo Ji-Zhuang, Li Yan-Qi |
| Polymorphisms of the UDP-glucuronosyl transferase 1A genes are associated with adverse events in cancer patients receiving irinotecan-based chemotherapy. The Tohoku journal of experimental medicine 2013 229 (2): 107-14. Inoue Kazuyuki, Sonobe Momoyo, Kawamura Yukinori, Etoh Takashi, Takagi Masakazu, Matsumura Takashi, Kikuyama Masataka, Kimura Midori, Minami Sato, Utsuki Hiroaki, Yamazaki Tomoaki, Suzuki Takayo, Tsuji Daiki, Hayashi Hideki, Itoh Kunihi |
| A novel system for predicting the toxicity of irinotecan based on statistical pattern recognition with UGT1A genotypes. International journal of oncology 2014 Oct 45 (4): 1381-90. Tsunedomi Ryouichi, Hazama Shoichi, Fujita Yusuke, Okayama Naoko, Kanekiyo Shinsuke, Inoue Yuka, Yoshino Shigefumi, Yamasaki Takahiro, Suehiro Yutaka, Oba Koji, Mishima Hideyuki, Sakamoto Junichi, Hamamoto Yoshihiko, Oka Masaa |
| XELIRI compared with FOLFIRI as a second-line treatment in patients with metastatic colorectal cancer. Oncology letters 2014 Oct 8 (4): 1864-1872. Cui Chengxu, Shu Chang, Yang Yi, Liu Junbao, Shi Shuping, Shao Zhujun, Wang Nan, Yang Ting, Hu Songni |
| Active cigarette smoking, variants in carcinogen metabolism genes and breast cancer risk among pre- and postmenopausal women in Ontario, Canada. The breast journal 0 20 (5): 468-80. Cotterchio Michelle, Mirea Lucia, Ozcelik Hilmi, Kreiger Nan |
| Variations of chromosome 2 gene expressions among patients with lung cancer or non-cancer. Cell biology and toxicology 2016 Jun . Bao Lianmin, Zhang Yong, Wang Jian, Wang Haiyun, Dong Nian, Su Xiaoqiong, Xu Menglin, Wang Xiangdo |
| UGT1A1*6, UGT1A7*3 and UGT1A9*1b polymorphisms are predictive markers for severe toxicity in patients with metastatic gastrointestinal cancer treated with irinotecan-based regimens. Oncology letters 2016 Nov 12 (5): 4231-4237. Cui Chengxu, Shu Chang, Cao Dandan, Yang Yi, Liu Junbao, Shi Shuping, Shao Zhujun, Wang Nan, Yang Ting, Liang Hao, Zou Shanshan, Hu Songni |
| Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis. BMC cancer 2017 Jun 17 (1): 437. Liu Dan, Li Jian, Gao Jing, Li Yanyan, Yang Rui, Shen L |
| Genetic polymorphisms in human UDP-glucuronosyltransferases 1A7 and the risk of gastrointestinal carcinomas: A systematic review and network meta-analysis. Oncotarget 2017 Sep 8 (39): 66371-66381. Zhang Yingshi, Hou Jun, Feng Fan, Li Dandan, Jiang Qiyu, Li Xiaojuan, Zhao Qingchun, Li Bo- |
| Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis. Pathology, research and practice 2018 Apr . Xie Zu-Cheng, Li Tian-Tian, Gan Bin-Liang, Gao Xiang, Gao Li, Chen Gang, Hu Xiao-H |
| Effect of UGT, SLCO, ABCB and ABCC polymorphisms on irinotecan toxicity. Medicina clinica 2018 Feb . García Gil Sara, Ramos Díaz Ruth, Nazco Casariego Gloria Julia, Llanos Muñoz Marta, Viña Romero Maria Micaela, Martín Calero Braulio, Pérez Pérez Jose Antonio, Gutiérrez Nicolás Fernan |
| The UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patients. Genomics & informatics 2022 Sep 20 (3): e29. Lee Choong-Kun, Chon Hong Jae, Kwon Woo Sun, Ban Hyo-Jeong, Kim Sang Cheol, Kim Hyunwook, Jeung Hei-Cheul, Chung Jimyung, Rha Sun You |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: